Eye drop with difluprednate for macular edema treatment

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9949926
SERIAL NO

14661295

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention aims to provide an eye drop for treating macular edema. The present invention provides an eye drop for treating macular edema, which contains difluprednate as an active ingredient. The eye drop can afford effects such as improvement of visual acuity and decreased foveal retinal thickness in macular edema.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
YAMAGATA UNIVERSITY1-4-12 KOJIRAKAWA-MACHI YAMAGATA-SHI YAMAGATA 990-8560

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abe, Sachi Yamagata, JP 3 2
Goto, Sakiko Yamagata, JP 3 2
Kirii, Eriko Yamagata, JP 3 2
Okumura, Atsushi Osaka, JP 17 294
Yamamoto, Teiko Tokyo, JP 5 2
Yamashita, Hidetoshi Yamagata, JP 34 227

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00